An Ecocert-approved, natural preservative that counts as gentle and non-irritating to the skin
Revolutionary Anti-Aging Peptide Science Modern aesthetic medicine has been transformed by the discovery of powerful peptide compounds that can reverse aging at the cellular level
Track Your Doses: When using the staggered method, it is easy to lose track
Your provider will assess your medical history, current medications, and any conditions that might make GLP-1 inappropriate
Key findings include: GLP3 monotherapy achieved 22.8-24.2% mean weight reduction at 48 weeks in phase 2 obesity trials (8-12 mg doses) Cagrilintide monotherapy produced 10.8% weight loss over 26 weeks in phase 2 studies (2.4 mg dose) CagriSema combination (cagrilintide + semaglutide) achieved 20.4% weight loss at 68 weeks in phase 3 REDEFINE trials Combination approaches consistently outperformed single-agent therapies across multiple dose ranges Studies demonstrated that 100% of participants receiving GLP3 8 mg or higher achieved at least 5% weight loss, with 75-83% achieving 15% or greater weight reduction[9]
These can include: Hypersensitivity or allergic reactions Nausea, vomiting, or diarrhea Headaches or dizziness Joint pain or stiffness A flushing sensation after injection It is important to note that these risks are rare and usually mild